Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06557434 · ClinicalTrials.gov registry record · NA

AV-23-001 AVAVA MIRIA Pilot Study

A NA study of Wrinkle and Skin Laxity, sponsored by AVAVA.

Active
Registry status
NA
Development phase
200
Enrollment target
2
Study locations

NCT06557434 is a NA study of Wrinkle and Skin Laxity that is active but no longer recruiting, run by AVAVA. The registered enrollment target is 200 participants, above the 112-participant average among 25 other Wrinkle trials with a reported enrollment target (79% higher). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06557434, a NA study of Wrinkle and Skin Laxity, is active but no longer recruiting, sponsored by AVAVA.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
2
Study locations

Study Summary

This non-significant risk study is intended to demonstrate the use of the MIRIA Skin Treatment System can show improvement in dermatologic conditions currently indicated for treatment with a laser (such as, but not limited to, benign pigmented lesions, benign cutaneous lesions, wrinkles, textural irregularities, or scars). The study is also intended to assist in determination of the optimal laser configuration and treatment parameters that most consistently yield results.

Interventions

  • DEVICE MIRIA

Study Locations (2)

New York

  • Skinfluence Long Island - Dix Hills
  • Laser and Skin Surgery Center of New York - New York

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2023-11-06
Est. Completion 2026-12-31
Phase NA

Sponsor

AVAVA

4 total trials

What the Registry Record Tells You About NCT06557434

The ClinicalTrials.gov registry entry for NCT06557434 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 112-participant average among 25 other Wrinkle trials with a reported enrollment target (79% higher). The listed sponsor is AVAVA, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Wrinkle appearing as the primary indexed condition, and to 1 intervention - of which MIRIA is the first listed.

NCT06557434 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06557434 about?

NCT06557434 is a clinical study titled "AV-23-001 AVAVA MIRIA Pilot Study". This non-significant risk study is intended to demonstrate the use of the MIRIA Skin Treatment System can show improvement in dermatologic conditions currently indicated for treatment with a laser (such as, but not limited to, benign pigmented lesions, benign cutaneous lesions, wrinkles, textural ir...

What is the current status of trial NCT06557434?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2023-11-06. Estimated completion is 2026-12-31.

What conditions does trial NCT06557434 study?

This clinical trial studies the following conditions: Wrinkle, Skin Laxity, Acne Scars - Mixed Atrophic and Hypertrophic, Scars, Pigmented Lesions.

What interventions are being tested in trial NCT06557434?

The interventions under investigation include: MIRIA (DEVICE).

Who is sponsoring clinical trial NCT06557434?

This trial is sponsored by AVAVA, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06557434 being conducted?

This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Wrinkle

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.